Warburg Pincus to invest up to $250 million in equity for the growth of RDL, which will focus on hospital system clinical laboratory outreach programs.
It was recently announced that Willkie client Warburg Pincus has agreed to invest up to $250 million in newly launched Regional Diagnostic Laboratories, Inc. Clinical laboratory industry veteran Brian C. Carr formed RDL in partnership with Warburg Pincus and a notable laboratory executive team. It is intended for RDL to become a national platform of regionally focused clinical laboratories primarily by acquiring or entering into partnerships with hospital-based laboratories. Based in Brentwood, Tennessee, RDL will provide health systems a more mission consistent way to obtain capital for other projects while keeping quality laboratory services local. The deal was handled by partners Steven Gartner, Robert Langdon, Michael Katz and Hillel Jacobson; of counsel Martin Miller and associates Brandon Ladoff and Nicholas Cirella.